Bandi di ricerca

Bando 2011 per il Biennio 2012-2013

Innovative treatments for neurometabolic and neurogenetic diseases and their complications

Targeting the endo-lysosomal system: development of novel therapeutic strategies to ameliorate neuropathology in lysosomal storage disorders

ALESSANDRO FRALDI, Istituto Telethon di Genetica e Medicina (TIGEM), Napoli

Drug repositioning in rho-linked cognitive impairment: Fasudil, a rock inhibitor as potential treatment in OPHN1 syndrome

ENRICO BERTINI, Ospedale Bambino Gesù, Unità Operativa delle Malattie Muscolari e Neurodegenerative, Laboratorio di Medicina Molecolare, Roma

Novel treatment for a genetic drug-resistant epileptic encephalopathy of infancy: virus delivered RNA interference in an animal model of Dravet syndrome

SILVANA FRANCESCHETTI, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, Dipartimento di Neurofidiopatologia e Centro per l’Epilessia, Milano

Neurological and visual impairment in Cobalamin C defect: a novel therapeutical approach based on antioxidant therapy

CARLO DIONISI-VICI, Ospedale Bambino Gesù, Dipartimento di Pediatria, Unità Operativa di Patologia Metabolica, Roma